Michael Bukhalo MD

Acne & Rosacea, Dermatologic Surgery

Physician

5301 Keystone Ct.Rolling Meadows, IL 60008
Phone+1 847-392-5440
Fax+1 847-385-0294

Dr. Bukhalo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bukhalo's full profile Already have an account?

Education & Training

University at BuffaloResidency, Dermatology, 1998 - 2001
Spartanburg Medical CenterInternship, Transitional Year, 1997 - 1998
University of Illinois College of MedicineClass of 1997
Northeastern Illinois UniversityB.S., Biology, Summa Cum Laude, 1992 - 1993
Oakton Community CollegeBachelor's, 1991 - 1992

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 2001 - 2029
NY State Medical License 1998 - 2019
SC State Medical License 1997 - 1998
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Physician Recognition Award American Medical Association, 2004
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
COMPLETED
PHASE3
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
COMPLETED
PHASE3
Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis
COMPLETED
PHASE3

Publications & Presentations

PubMed

Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.
Nina Magnolo, Jennifer Soung, John Frew, Antonio Costanzo, Hiram Ruiz-Santiago
Dermatology and Therapy. 2026-07-01
2 citations
Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-we...
Kim A Papp, Shahram Jacobs, Howard Sofen, Michael Bukhalo, Elisa Muscianisi
Journal of the American Academy of Dermatology. 2026-01-01
1 citations
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.
Andrew F Alexis, Michael Bukhalo, Fran E Cook-Bolden, James Q Del Rosso, Zoe D Draelos
American Journal of Clinical Dermatology. 2026-01-01

Journal Articles

Clinical Study Results of Desoximetasone Spray, 025% in Moderate to Severe Psoriasis
Kircik L, Lebwohl M, Del Rosso J, Bagel J, Gold L, Weiss J, Journal of Drugs in Dermatology, 1/1/2013
Calcipotriene Plus Betamethasone Dipropionate Topical Suspension for the Treatment of Mild to Moderate Psoriasis Vulgaris on the body: A Randomized, Double-blind, Vehi...
Menter A, Gold L, Bukhalo M, Grekin S, Kempers S, Boyce B, Ganslandt C, Villumsen J, Lenwohl M, Journal of Drugs in Dermatology, 1/1/2013
Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratosis
Bukhalo M, The Journal of Clinical and Aesthetic Dermatology, 1/1/2009

Abstracts/Posters

A Novel Aerosol Foam Formulation of Calcipotriene (Cal) 0.005% Plus Betamethasone Dipropionate (BD) 0.064% is More Efficacious Than Cal and BD Foam Alone in Treating P...
Lebwohl M, Tyring S, Bukhalo M, Alonso-Llamazares J, Oleses M, Lowson D, Yamauchi P, 73rd Annual Meeting of the American Academy of Dermatology, San Francisco, CA, 1/20/2015
A Phase 2 Study of Photodynamic Therapy (PDT) with Aminolevulinic Acid HCI (ALA) 20% Topical Solution + Blue Light vs ALA Topical Solution Vehicle + Blue Light Using S...
Pariser D, McConnehey D, Matheson R, Kempers S, Guenthner S, Bukhalo M, 71st Annual Meeting of the American Academy of Dermatology, Miami Beach, FL, 1/1/2013
Randomized, Parellel-Group, Double-Blind, Vehicle-Controlled, Multicenter Phase 3 Study of the Efficacy and Safety of PEP005 (ingenol mebutate) Gel, 0.015% in Patients...
Lebwohl M, Melgaard A, Xu Z, 22nd World Congress of Dermatology, Seoul, Korea, 1/24/2011

Lectures

A Novel Aerosol Foam Formulation of Calcipotriene (Cal) 0.005% Plus Betamethasone Dipropionate (BD) 0.064% is More Efficacious Than Cal and BD Foam Alone in Treating P...
Kaua'I, HI - 1/1/2015
Use of Light Sources for Acne Therapy
St. Thomas, VI - 1/1/2009
New Trends in Acne Therapy
San Antonio, TX - 1/1/2006

Press Mentions

Mindera Health™ Announces Publication of Randomized, Prospective Clinical Utility Study Demonstrating Improved Psoriasis Patient OutcomesMay 13th, 2025